SCID mice as an in vivo model of human cord blood hematopoiesis

J. Vormoor, T. Lapidot, F. Pflumio, G. Risdon, B. Patterson, Hal Broxmeyer, J. E. Dick

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Cord blood is increasingly used as an alternative stem cell source for autologous and allogeneic transplantation, particularly in pediatric patients. We therefore adopted our protocol for transplanting human adult bone marrow cells into severe combined immunodeficient (SCID) mice to develop an in vivo model for cord blood hematopoiesis. Intravenous injection of unfractionated or Ficoll-separated cord blood cells into sublethally irradiated SCID mice led to high levels of human hematopoiesis in the majority of the recipients. Multilineage human hematopoiesis including committed and multipotential myeloerythroid progenitors as well as CD19+ B-lymphoid cells were observed in the murine bone marrow for at least 18 weeks. Together, these data indicate that the SCID mice were engrafted with an immature cell that was able to maintain multiple progenitor lineages in vivo. In contrast to our experiences with adult bone marrow, high levels of human cell engraftment in the mouse could be achieved without exogenous cytokine treatment, suggesting that the cord blood cells respond differently to the murine microenvironment. Alternatively, the cord blood cells might have been able to provide themselves with the necessary growth factors in a paracrine fashion. This model will be useful in gaining new insights into the biology of immature human cord blood progenitors and cord blood transplantation.

Original languageEnglish (US)
Pages (from-to)316-322
Number of pages7
JournalBlood Cells
Volume20
Issue number2-3
StatePublished - 1994
Externally publishedYes

Fingerprint

SCID Mice
Hematopoiesis
Fetal Blood
Blood Cells
Bone Marrow
Ficoll
Autologous Transplantation
Homologous Transplantation
Intravenous Injections
Bone Marrow Cells
Intercellular Signaling Peptides and Proteins
Stem Cells
Transplantation
Lymphocytes
Pediatrics
Cytokines

Keywords

  • bone marrow transplantation
  • cord blood
  • hematopoiesis
  • SCID mice
  • stem cells

ASJC Scopus subject areas

  • Hematology

Cite this

Vormoor, J., Lapidot, T., Pflumio, F., Risdon, G., Patterson, B., Broxmeyer, H., & Dick, J. E. (1994). SCID mice as an in vivo model of human cord blood hematopoiesis. Blood Cells, 20(2-3), 316-322.

SCID mice as an in vivo model of human cord blood hematopoiesis. / Vormoor, J.; Lapidot, T.; Pflumio, F.; Risdon, G.; Patterson, B.; Broxmeyer, Hal; Dick, J. E.

In: Blood Cells, Vol. 20, No. 2-3, 1994, p. 316-322.

Research output: Contribution to journalArticle

Vormoor, J, Lapidot, T, Pflumio, F, Risdon, G, Patterson, B, Broxmeyer, H & Dick, JE 1994, 'SCID mice as an in vivo model of human cord blood hematopoiesis', Blood Cells, vol. 20, no. 2-3, pp. 316-322.
Vormoor J, Lapidot T, Pflumio F, Risdon G, Patterson B, Broxmeyer H et al. SCID mice as an in vivo model of human cord blood hematopoiesis. Blood Cells. 1994;20(2-3):316-322.
Vormoor, J. ; Lapidot, T. ; Pflumio, F. ; Risdon, G. ; Patterson, B. ; Broxmeyer, Hal ; Dick, J. E. / SCID mice as an in vivo model of human cord blood hematopoiesis. In: Blood Cells. 1994 ; Vol. 20, No. 2-3. pp. 316-322.
@article{1978470497434b16a86b5ac0769c87da,
title = "SCID mice as an in vivo model of human cord blood hematopoiesis",
abstract = "Cord blood is increasingly used as an alternative stem cell source for autologous and allogeneic transplantation, particularly in pediatric patients. We therefore adopted our protocol for transplanting human adult bone marrow cells into severe combined immunodeficient (SCID) mice to develop an in vivo model for cord blood hematopoiesis. Intravenous injection of unfractionated or Ficoll-separated cord blood cells into sublethally irradiated SCID mice led to high levels of human hematopoiesis in the majority of the recipients. Multilineage human hematopoiesis including committed and multipotential myeloerythroid progenitors as well as CD19+ B-lymphoid cells were observed in the murine bone marrow for at least 18 weeks. Together, these data indicate that the SCID mice were engrafted with an immature cell that was able to maintain multiple progenitor lineages in vivo. In contrast to our experiences with adult bone marrow, high levels of human cell engraftment in the mouse could be achieved without exogenous cytokine treatment, suggesting that the cord blood cells respond differently to the murine microenvironment. Alternatively, the cord blood cells might have been able to provide themselves with the necessary growth factors in a paracrine fashion. This model will be useful in gaining new insights into the biology of immature human cord blood progenitors and cord blood transplantation.",
keywords = "bone marrow transplantation, cord blood, hematopoiesis, SCID mice, stem cells",
author = "J. Vormoor and T. Lapidot and F. Pflumio and G. Risdon and B. Patterson and Hal Broxmeyer and Dick, {J. E.}",
year = "1994",
language = "English (US)",
volume = "20",
pages = "316--322",
journal = "Blood Cells, Molecules, and Diseases",
issn = "1079-9796",
publisher = "Academic Press Inc.",
number = "2-3",

}

TY - JOUR

T1 - SCID mice as an in vivo model of human cord blood hematopoiesis

AU - Vormoor, J.

AU - Lapidot, T.

AU - Pflumio, F.

AU - Risdon, G.

AU - Patterson, B.

AU - Broxmeyer, Hal

AU - Dick, J. E.

PY - 1994

Y1 - 1994

N2 - Cord blood is increasingly used as an alternative stem cell source for autologous and allogeneic transplantation, particularly in pediatric patients. We therefore adopted our protocol for transplanting human adult bone marrow cells into severe combined immunodeficient (SCID) mice to develop an in vivo model for cord blood hematopoiesis. Intravenous injection of unfractionated or Ficoll-separated cord blood cells into sublethally irradiated SCID mice led to high levels of human hematopoiesis in the majority of the recipients. Multilineage human hematopoiesis including committed and multipotential myeloerythroid progenitors as well as CD19+ B-lymphoid cells were observed in the murine bone marrow for at least 18 weeks. Together, these data indicate that the SCID mice were engrafted with an immature cell that was able to maintain multiple progenitor lineages in vivo. In contrast to our experiences with adult bone marrow, high levels of human cell engraftment in the mouse could be achieved without exogenous cytokine treatment, suggesting that the cord blood cells respond differently to the murine microenvironment. Alternatively, the cord blood cells might have been able to provide themselves with the necessary growth factors in a paracrine fashion. This model will be useful in gaining new insights into the biology of immature human cord blood progenitors and cord blood transplantation.

AB - Cord blood is increasingly used as an alternative stem cell source for autologous and allogeneic transplantation, particularly in pediatric patients. We therefore adopted our protocol for transplanting human adult bone marrow cells into severe combined immunodeficient (SCID) mice to develop an in vivo model for cord blood hematopoiesis. Intravenous injection of unfractionated or Ficoll-separated cord blood cells into sublethally irradiated SCID mice led to high levels of human hematopoiesis in the majority of the recipients. Multilineage human hematopoiesis including committed and multipotential myeloerythroid progenitors as well as CD19+ B-lymphoid cells were observed in the murine bone marrow for at least 18 weeks. Together, these data indicate that the SCID mice were engrafted with an immature cell that was able to maintain multiple progenitor lineages in vivo. In contrast to our experiences with adult bone marrow, high levels of human cell engraftment in the mouse could be achieved without exogenous cytokine treatment, suggesting that the cord blood cells respond differently to the murine microenvironment. Alternatively, the cord blood cells might have been able to provide themselves with the necessary growth factors in a paracrine fashion. This model will be useful in gaining new insights into the biology of immature human cord blood progenitors and cord blood transplantation.

KW - bone marrow transplantation

KW - cord blood

KW - hematopoiesis

KW - SCID mice

KW - stem cells

UR - http://www.scopus.com/inward/record.url?scp=0028592687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028592687&partnerID=8YFLogxK

M3 - Article

C2 - 7538337

AN - SCOPUS:0028592687

VL - 20

SP - 316

EP - 322

JO - Blood Cells, Molecules, and Diseases

JF - Blood Cells, Molecules, and Diseases

SN - 1079-9796

IS - 2-3

ER -